FELANTE

Serial Number 79389127
Registration 7646723
700

Registration Progress

Application Filed
Dec 29, 2023
Under Examination
Approved for Publication
Nov 26, 2024
Published for Opposition
Nov 26, 2024
Registered
Jan 14, 2025

Trademark Image

FELANTE

Basic Information

Serial Number
79389127
Registration Number
7646723
Filing Date
December 29, 2023
Registration Date
January 14, 2025
Published for Opposition
November 26, 2024
Drawing Code
4

Status Summary

Current Status
Active
Status Code
700
Status Date
Jan 14, 2025
Registration
Registered
Classes
005

Rights Holder

Sanovel Ilaç Sanayi ve Ticaret Anonim Sirketi

99
Address
Istinye Mah. Balabandere Cad. 14- 1
Sariyer Istanbul
TR

Ownership History

Sanovel Ilaç Sanayi ve Ticaret Anonim Sirketi

Original Applicant
99
TR

Sanovel Ilaç Sanayi ve Ticaret Anonim Sirketi

Owner at Publication
99
TR

Sanovel Ilaç Sanayi ve Ticaret Anonim Sirketi

Original Registrant
99
TR

Legal Representation

Attorney
Margaret McHugh

USPTO Deadlines

Next Deadline
1995 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2025-01-14)
Due Date
January 14, 2031
Grace Period Ends
July 14, 2031
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

26 events
Date Code Type Description Documents
Jul 26, 2025 OPNX P NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB Loading...
Jul 7, 2025 OPNR P NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB Loading...
Jul 7, 2025 OPNS P NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB Loading...
Apr 15, 2025 FICR P FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB Loading...
Jan 14, 2025 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Jan 14, 2025 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED Loading...
Nov 26, 2024 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Nov 26, 2024 PUBO A PUBLISHED FOR OPPOSITION Loading...
Nov 20, 2024 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Oct 31, 2024 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Oct 31, 2024 GNEA F EXAMINERS AMENDMENT E-MAILED Loading...
Oct 31, 2024 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Oct 31, 2024 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
Oct 31, 2024 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
Oct 3, 2024 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Oct 2, 2024 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Oct 2, 2024 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
May 9, 2024 RFNT P REFUSAL PROCESSED BY IB Loading...
Apr 15, 2024 RFCS P NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Loading...
Apr 15, 2024 RFRR P REFUSAL PROCESSED BY MPU Loading...
Mar 27, 2024 RFCR E NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Loading...
Mar 26, 2024 CNRT R NON-FINAL ACTION WRITTEN Loading...
Mar 19, 2024 DOCK D ASSIGNED TO EXAMINER Loading...
Feb 16, 2024 MAFR O APPLICATION FILING RECEIPT MAILED Loading...
Feb 12, 2024 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Feb 10, 2024 REPR M SN ASSIGNED FOR SECT 66A APPL FROM IB Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system, hematological, infection, pain, inflammatory, and febrile related diseases and disorders

Classification

International Classes
005